These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Breast Cancer Res Treat; 2009 Oct; 117(3):561-7. PubMed ID: 19153828 [Abstract] [Full Text] [Related]
7. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status. Ilanchezhian S, Thangaraju M, Sachdanandam P. Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439 [Abstract] [Full Text] [Related]
8. The effect of tamoxifen treatment on serum cholesterol fractions in breast cancer women. Dziewulska-Bokiniec A, Wojtacki J, Skokowski J, Kortas B. Neoplasma; 1994 Nov; 41(1):13-6. PubMed ID: 8202188 [Abstract] [Full Text] [Related]
9. Postoperative changes in lipid profile: their relations with inflammatory markers and endocrine mediators. Canivet JL, Damas P, Buret J, Lamy M. Acta Anaesthesiol Belg; 1989 Nov; 40(4):263-8. PubMed ID: 2696316 [Abstract] [Full Text] [Related]
12. Salubrious effect of vitamin C and vitamin E on tamoxifen-treated women in breast cancer with reference to plasma lipid and lipoprotein levels. Babu JR, Sundravel S, Arumugam G, Renuka R, Deepa N, Sachdanandam P. Cancer Lett; 2000 Apr 03; 151(1):1-5. PubMed ID: 10766415 [Abstract] [Full Text] [Related]
14. Duration of tamoxifen effect on lipidemic profile of postmenopausal breast cancer patients following deprivation of treatment. Markopoulos C, Chrissochou M, Antonopoulou Z, Xepapadakis G, Papadiamantis J, Tzoracoleftherakis E, Gogas H. Oncology; 2006 Apr 03; 70(4):301-5. PubMed ID: 17047401 [Abstract] [Full Text] [Related]
15. Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer. Sawada S, Sato K, Kusuhara M, Ayaori M, Yonemura A, Tamaki K, Hiraide H, Mochizuki H, Ohsuzu F. Acta Oncol; 2005 Apr 03; 44(2):134-41. PubMed ID: 15788292 [Abstract] [Full Text] [Related]
16. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer. Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T. Int J Oncol; 2005 Apr 03; 26(4):1025-31. PubMed ID: 15753998 [Abstract] [Full Text] [Related]
17. Effect of cancer treatment modalities on serum lipids and lipoproteins among women with carcinoma of the breast. Ray A, Jain D, Yadav R, Naik SL, Sharma S, Bahadur AK, Sharma BK. Indian J Physiol Pharmacol; 2001 Jul 03; 45(3):337-44. PubMed ID: 11881573 [Abstract] [Full Text] [Related]
18. Studies on the changes in plasma lipids and lipoproteins in CMF treated breast cancer patients. Subramaniam S, Marar T, Devi CS. Biochem Int; 1991 Aug 03; 24(6):1015-24. PubMed ID: 1781779 [Abstract] [Full Text] [Related]